A Supreme Court case over whether to tighten restrictions on mifepristone – one of two drugs used in the medication abortion regimen – could destabilize the American pharmaceutical industry, deterring companies from developing new drugs and even inspiring copycat lawsuits intended to revoke authorization of other politically contentious medications. Read more at 19th News
“They’re not legitimate medical groups sounding an alarm. They’re ideological organizations, basically registering a website and using it to roll back reproductive rights,” Caroline Ciccone, president of the watchdog group Accountable.Us, said Thursday. “Basically, it’s a contrived coalition of extremist groups.” Read more at HuffPost
Adkins’ concerns go to the heart of a problem that has bedeviled scientists for at least a decade: the judicial system’s repeated adoption of poor-quality evidence to justify litigation and legislation to restrict abortion. Often that evidence is produced by the anti-abortion movement itself. Read more at The Guardian
The appeals court ruling under review “threatens to destabilize the pharmaceutical industry, which relies both on FDA’s ability to make predictive judgments and on courts not second-guessing those scientific judgments,” the lawyers wrote. Read more at NBC News
Doctors across the country told The 19th that they have struggled to stay on top of the latest developments in abortion lawsuits since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, which overturned federal abortion protections. That confusion, some said, could stop physicians even from providing legal pregnancy-related health care. Read more … Read more
Whatever the court decides could have sweeping ramifications. While the pills will likely stay on the market, there could be some significant changes to access, even in states where abortion remains legal and protected. Read more at The Hill
US supreme court agrees to consider abortion pill access “You can’t just bring random lawsuits in court. You actually have to have been harmed by something,” said Greer Donley, an associate law professor at the University of Pittsburgh Law School. “That’s really what standing analysis is all about, to try to figure out if if … Read more
The looming case is expected to be the most sweeping abortion issue the high court examines since overturning Roe v. Wade, with implications that extend far beyond reproductive health and could impact how a vast array of drugs are approved and regulated. Read more at Politico
Democratic New Jersey Gov. Phil Murphy on Wednesday said “everything is on the table” if the Supreme Court decides to outlaw the abortion drug mifepristone, which has been approved by the Food and Drug Administration, and warned Republicans who are moving toward restricting reproductive rights that they are “playing with fire.” Read more at Huffpost … Read more
The plaintiffs in this case are questioning the FDA’s scientific process for evaluating the benefits of drugs. According to the Alliance for Hippocratic Medicine, if the appeals court rules in favor of the plaintiffs, its effects will extend beyond abortion access: A constant barrage of legal challenges to federal approval could discourage drugmakers from bringing … Read more
